Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -11.84% is 61% above its 5-year average of -29.98%, near the high end of its 5-year range (-315.92%–-9.40%).
1.58% above its 12-month average of -12.03%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -13.05%.
EBITDA MARGIN
-11.84%
EBITDA MARGIN AVG TTM
-12.03%
EBITDA MARGIN AVG 3Y
-19.87%
EBITDA MARGIN AVG 5Y
-29.98%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+1.58%
CURRENT VS 3Y AVG
+40.40%
CURRENT VS 5Y AVG
+60.51%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Tempus AI, Inc.
Market Cap
$10.34B
EBITDA Margin
-11.84%
TTM Avg
-12.03%
3Y Avg
-19.87%
5Y Avg
-29.98%
Market Cap
$10.51B
EBITDA Margin
27.02%
TTM Avg
27.38%
3Y Avg
26.41%
5Y Avg
26.36%
Market Cap
$10.14B
EBITDA Margin
10.47%
TTM Avg
10.43%
3Y Avg
10.38%
5Y Avg
10.85%
Market Cap
$10.58B
EBITDA Margin
15.05%
TTM Avg
14.69%
3Y Avg
13.35%
5Y Avg
14.10%
Market Cap
$10.66B
EBITDA Margin
2.15%
TTM Avg
3.41%
3Y Avg
4.20%
5Y Avg
4.49%
Market Cap
$10.01B
EBITDA Margin
20.41%
TTM Avg
18.54%
3Y Avg
20.94%
5Y Avg
21.85%
Market Cap
$9.94B
EBITDA Margin
18.42%
TTM Avg
17.41%
3Y Avg
19.12%
5Y Avg
20.05%
Market Cap
$10.80B
EBITDA Margin
19.75%
TTM Avg
19.29%
3Y Avg
19.87%
5Y Avg
21.06%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tempus AI, Inc. (TEM) | $10.34B | -11.84% | -12.03% | -19.87% | -29.98% |
| The Cooper Companies, Inc. (COO)vs › | $10.51B | 27.02% | 27.38% | 26.41% | 26.36% |
| The Ensign Group, Inc. (ENSG)vs › | $10.14B | 10.47% | 10.43% | 10.38% | 10.85% |
| Universal Health Services, Inc. (UHS)vs › | $10.58B | 15.05% | 14.69% | 13.35% | 14.10% |
| Henry Schein, Inc. (HSIC)vs › | $10.07B | 8.11% | 8.11% | 8.28% | 8.19% |
| Molina Healthcare, Inc. (MOH)vs › | $10.66B | 2.15% | 3.41% | 4.20% | 4.49% |
| Globus Medical, Inc. (GMED)vs › | $10.01B | 20.41% | 18.54% | 20.94% | 21.85% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.94B | 18.42% | 17.41% | 19.12% | 20.05% |
| Align Technology, Inc. (ALGN)vs › | $10.80B | 19.75% | 19.29% | 19.87% | 21.06% |
| Bio-Techne Corporation (TECH)vs › | $11.29B | 28.74% | 23.07% | 27.33% | 30.04% |
Gross Margin
64.0%
EBITDA Margin
-11.8%
Operating Margin
-19.8%
Net Margin
-17.8%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -13.05% |
| 2026-03-31 | -16.82% |
| 2025-12-31 | -9.40% |
| 2025-09-30 | -10.16% |
| 2025-06-30 | -10.72% |
| 2025-03-31 | -18.90% |
| 2024-12-31 | -20.55% |
| 2024-09-30 | -24.42% |
| 2024-06-30 | -315.92% |
| 2024-03-31 | -30.23% |
| 2023-12-31 | -29.62% |
| 2023-09-30 | -26.73% |
| 2023-06-30 | -27.80% |
| 2023-03-31 | -39.63% |
| 2022-12-31 | -49.83% |
| 2021-12-31 | -66.93% |
| 2021-09-30 | -111.79% |
| 2021-06-30 | -84.89% |
| 2021-03-31 | -84.89% |
| 2020-12-31 | -35.73% |
| 2020-09-30 | -91.73% |
| 2020-06-30 | -241.17% |
| 2020-03-31 | -241.17% |
